Mixed antimony(V) complexes with different sugars to modulate the oral bioavailability of pentavalent antimonial drugs
Previous studies have shown that the association of the drug meglumine antimoniate (MA) with β-cyclodextrin can improve its bioavailability by the oral route. In this work, ribose and maltose were investigated for their ability to form mixed or association complexes with MA, release MA and modulate...
Saved in:
Published in: | Molecules (Basel, Switzerland) Vol. 19; no. 5; pp. 5478 - 5489 |
---|---|
Main Authors: | , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Switzerland
MDPI
28-04-2014
MDPI AG |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Previous studies have shown that the association of the drug meglumine antimoniate (MA) with β-cyclodextrin can improve its bioavailability by the oral route. In this work, ribose and maltose were investigated for their ability to form mixed or association complexes with MA, release MA and modulate the serum levels of Sb after oral administration in mice. Analysis of the MA/ribose composition by high performance liquid chromatography coupled to mass spectrometry (LCMS-IT-TOF) revealed the presence of mixed meglumine-Sb-ribose and Sb-ribose complexes. Analysis of the MA/maltose composition suggested the formation of MA-maltose association compounds. Circular dichroism characterization of these compositions following dilution in water at 37 °C suggested a partial and slow dissociation of the association compounds. When the MA/ribose composition was administered orally and compared to MA, the serum concentration of Sb was significantly lower after 1 h and greater after 3 h. On the other hand, the MA/maltose composition showed similar serum Sb concentration after 1 h and higher level of Sb after 3 h, when compared to MA. In conclusion, the present study has demonstrated the formation of mixed or association complexes of MA with sugars, such as maltose and ribose, which promoted sustained serum level of Sb after oral administration. |
---|---|
AbstractList | Previous studies have shown that the association of the drug meglumine antimoniate (MA) with β-cyclodextrin can improve its bioavailability by the oral route. In this work, ribose and maltose were investigated for their ability to form mixed or association complexes with MA, release MA and modulate the serum levels of Sb after oral administration in mice. Analysis of the MA/ribose composition by high performance liquid chromatography coupled to mass spectrometry (LCMS-IT-TOF) revealed the presence of mixed meglumine-Sb-ribose and Sb-ribose complexes. Analysis of the MA/maltose composition suggested the formation of MA-maltose association compounds. Circular dichroism characterization of these compositions following dilution in water at 37 °C suggested a partial and slow dissociation of the association compounds. When the MA/ribose composition was administered orally and compared to MA, the serum concentration of Sb was significantly lower after 1 h and greater after 3 h. On the other hand, the MA/maltose composition showed similar serum Sb concentration after 1 h and higher level of Sb after 3 h, when compared to MA. In conclusion, the present study has demonstrated the formation of mixed or association complexes of MA with sugars, such as maltose and ribose, which promoted sustained serum level of Sb after oral administration. |
Author | Demicheli, Cynthia Andrade, Aretha Priscilla S Ferreira, Weverson A Islam, Arshad Fernandes, Flaviana R Frézard, Frédéric |
AuthorAffiliation | 1 Department of Chemistry, Institute of Exact Sciences – Federal University of Minas Gerais (UFMG), Av. Antônio Carlos 6627, Belo Horizonte 31270-901, MG, Brazil 2 Department of Physiology and Biophysics, Institute of Biological Sciences – Federal University of Minas Gerais (UFMG), Av. Antônio Carlos 6627, Belo Horizonte 31270-901, MG, Brazil |
AuthorAffiliation_xml | – name: 2 Department of Physiology and Biophysics, Institute of Biological Sciences – Federal University of Minas Gerais (UFMG), Av. Antônio Carlos 6627, Belo Horizonte 31270-901, MG, Brazil – name: 1 Department of Chemistry, Institute of Exact Sciences – Federal University of Minas Gerais (UFMG), Av. Antônio Carlos 6627, Belo Horizonte 31270-901, MG, Brazil |
Author_xml | – sequence: 1 givenname: Weverson A surname: Ferreira fullname: Ferreira, Weverson A organization: Department of Chemistry, Institute of Exact Sciences - Federal University of Minas Gerais (UFMG), Av. Antônio Carlos 6627, Belo Horizonte 31270-901, MG, Brazil – sequence: 2 givenname: Arshad surname: Islam fullname: Islam, Arshad organization: Department of Chemistry, Institute of Exact Sciences - Federal University of Minas Gerais (UFMG), Av. Antônio Carlos 6627, Belo Horizonte 31270-901, MG, Brazil – sequence: 3 givenname: Aretha Priscilla S surname: Andrade fullname: Andrade, Aretha Priscilla S organization: Department of Chemistry, Institute of Exact Sciences - Federal University of Minas Gerais (UFMG), Av. Antônio Carlos 6627, Belo Horizonte 31270-901, MG, Brazil – sequence: 4 givenname: Flaviana R surname: Fernandes fullname: Fernandes, Flaviana R organization: Department of Physiology and Biophysics, Institute of Biological Sciences - Federal University of Minas Gerais (UFMG), Av. Antônio Carlos 6627, Belo Horizonte 31270-901, MG, Brazil – sequence: 5 givenname: Frédéric surname: Frézard fullname: Frézard, Frédéric organization: Department of Physiology and Biophysics, Institute of Biological Sciences - Federal University of Minas Gerais (UFMG), Av. Antônio Carlos 6627, Belo Horizonte 31270-901, MG, Brazil – sequence: 6 givenname: Cynthia surname: Demicheli fullname: Demicheli, Cynthia email: demichel@netuno.lcc.ufmg.br organization: Department of Chemistry, Institute of Exact Sciences - Federal University of Minas Gerais (UFMG), Av. Antônio Carlos 6627, Belo Horizonte 31270-901, MG, Brazil. demichel@netuno.lcc.ufmg.br |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24786687$$D View this record in MEDLINE/PubMed |
BookMark | eNplkctuFDEQRS0URB7wAWyQl7CY4Hd3b5BQxCNSEBtg26q2q2ccudsj2z3J_D0OE6JEWVXpVt1TKt1TcjTHGQl5y9m5lB37OMWAdgmYece0Vk37gpxwJdhKMtUdPeqPyWnO14wJrrh-RY5F3TWmbU7I7oe_RUdhLn6K8_79nw_Uxmkb8BYzvfFlQ50fR0w4F5qXNaRMS6RTdEuAgrRskMYEgQ4-wg58gMEHX_Y0jnRbPVULd9Z7vq-bLi3r_Jq8HCFkfHNfz8jvr19-XXxfXf38dnnx-WplldFl5ZTpRiWFkg6NlVpAbQQXuuqta3GADqzRjRHKORjagUmOjeJWSjRdw-QZuTxwXYTrfpv8BGnfR_D9PyGmdQ-peBuw58JAKwcQA3eKQaUjY-PQctQWGyYq69OBtV2GCZ2tf9XPn0CfTma_6ddx1xvRMKN1BfADwKaYc8LxwctZfxdo_yzQ6nn3-OiD43-C8i82hqRb |
CitedBy_id | crossref_primary_10_3390_molecules28134959 crossref_primary_10_1016_j_ecoenv_2022_113317 crossref_primary_10_1016_j_ica_2018_02_005 crossref_primary_10_1016_j_etap_2023_104160 crossref_primary_10_1016_j_poly_2015_05_004 crossref_primary_10_1071_EN19156 crossref_primary_10_1111_cbdd_13757 crossref_primary_10_1016_j_chemosphere_2023_138494 crossref_primary_10_2217_nnm_2019_0095 |
Cites_doi | 10.3390/molecules14072317 10.1007/s00216-006-0456-8 10.1023/A:1009200330741 10.1007/s10534-006-0001-4 10.1002/aoc.425 10.1093/clind/24.4.684 10.1093/cid/cis474 10.1128/AAC.48.1.100-103.2004 10.1016/j.ijpharm.2007.06.029 10.1002/bdd.695 10.1128/AAC.00639-13 10.1016/S0304-4165(02)00198-8 10.1016/j.ijpharm.2006.06.014 10.1056/NEJMoa021556 10.1016/j.jinorgbio.2007.10.010 10.1016/j.ica.2005.09.003 10.1371/journal.pone.0035671 10.1517/17425247.2010.529897 |
ContentType | Journal Article |
Copyright | 2014 by the authors. 2014 |
Copyright_xml | – notice: 2014 by the authors. 2014 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 5PM DOA |
DOI | 10.3390/molecules19055478 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef |
DatabaseTitleList | MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: http://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry |
EISSN | 1420-3049 |
EndPage | 5489 |
ExternalDocumentID | oai_doaj_org_article_126a83ba2b1d40ad8ee00fb81e5ce702 10_3390_molecules19055478 24786687 |
Genre | Journal Article |
GroupedDBID | --- 0R~ 123 2WC 3V. 53G 5VS 7X7 88E 8FE 8FG 8FH 8FI 8FJ A8Z AADQD AAFWJ AAHBH ABDBF ABJCF ABUWG ACGFO ACIWK ACPRK AEGXH AENEX AFKRA AFPKN AFRAH AFZYC AIAGR ALIPV ALMA_UNASSIGNED_HOLDINGS BBNVY BENPR BHPHI BPHCQ BVXVI CCPQU CGR CS3 CUY CVF D1I DIK DU5 E3Z EBD ECM EIF EMOBN ESTFP ESX FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE HZ~ I09 IPNFZ KB. KQ8 LK8 M1P M7P MODMG M~E NPM O-U O9- OK1 P2P PDBOC PIMPY PQQKQ PROAC PSQYO RIG RPM SV3 TR2 TUS UKHRP ~8M AAYXX CITATION 5PM |
ID | FETCH-LOGICAL-c465t-d469f43243de6c352a3de21254698d8eba9ac657624ddab8b031e741c33e69703 |
IEDL.DBID | RPM |
ISSN | 1420-3049 |
IngestDate | Tue Oct 22 15:04:40 EDT 2024 Tue Sep 17 21:27:22 EDT 2024 Thu Nov 21 23:20:06 EST 2024 Sat Sep 28 08:39:21 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
License | Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c465t-d469f43243de6c352a3de21254698d8eba9ac657624ddab8b031e741c33e69703 |
Notes | These authors contributed equally to this work. |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6270655/ |
PMID | 24786687 |
PageCount | 12 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_126a83ba2b1d40ad8ee00fb81e5ce702 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6270655 crossref_primary_10_3390_molecules19055478 pubmed_primary_24786687 |
PublicationCentury | 2000 |
PublicationDate | 20140428 |
PublicationDateYYYYMMDD | 2014-04-28 |
PublicationDate_xml | – month: 4 year: 2014 text: 20140428 day: 28 |
PublicationDecade | 2010 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland |
PublicationTitle | Molecules (Basel, Switzerland) |
PublicationTitleAlternate | Molecules |
PublicationYear | 2014 |
Publisher | MDPI MDPI AG |
Publisher_xml | – name: MDPI – name: MDPI AG |
References | Demicheli (ref_18) 1999; 12 Martins (ref_9) 2008; 347 Ferreira (ref_14) 2006; 19 Demicheli (ref_13) 2006; 359 Demicheli (ref_11) 2010; 7 Demicheli (ref_17) 2003; 17 Martins (ref_6) 2006; 325 Frezard (ref_7) 2008; 102 Demicheli (ref_12) 2002; 1570 Sundar (ref_3) 2002; 347 Demicheli (ref_8) 2004; 48 Hansen (ref_16) 2006; 385 Sundar (ref_4) 2012; 55 Fernandes (ref_5) 2013; 57 Berman (ref_2) 1997; 24 Ribeiro (ref_10) 2010; 31 Alvar (ref_1) 2012; 7 Demicheli (ref_15) 2009; 14 |
References_xml | – volume: 14 start-page: 2317 year: 2009 ident: ref_15 article-title: Pentavalent antimonials: New perspectives for old drugs publication-title: Molecules doi: 10.3390/molecules14072317 contributor: fullname: Demicheli – volume: 385 start-page: 821 year: 2006 ident: ref_16 article-title: Mass spectrometric identification and characterization of antimony complexes with ribose-containing biomolecules publication-title: Anal. Bioanal. Chem. doi: 10.1007/s00216-006-0456-8 contributor: fullname: Hansen – volume: 12 start-page: 63 year: 1999 ident: ref_18 article-title: Physico-chemical characterization of meglumine antimoniate publication-title: BioMetals doi: 10.1023/A:1009200330741 contributor: fullname: Demicheli – volume: 19 start-page: 573 year: 2006 ident: ref_14 article-title: Characterization of reactions of antimoniate and meglumine antimoniate with a guanine ribonucleoside at different pH publication-title: Biometals doi: 10.1007/s10534-006-0001-4 contributor: fullname: Ferreira – volume: 17 start-page: 226 year: 2003 ident: ref_17 article-title: Pentavalent organoantimonial derivatives: Two simple and efficient synthetic methods for meglumine antimonate publication-title: Appl. Organomet. Chem. doi: 10.1002/aoc.425 contributor: fullname: Demicheli – volume: 24 start-page: 684 year: 1997 ident: ref_2 article-title: Human leishmaniasis: Clinical, diagnostic, and chemotherapeutic developments in the last 10 years publication-title: Clin. Infect. Dis. doi: 10.1093/clind/24.4.684 contributor: fullname: Berman – volume: 55 start-page: 543 year: 2012 ident: ref_4 article-title: Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use publication-title: Clin. Infect. Dis. doi: 10.1093/cid/cis474 contributor: fullname: Sundar – volume: 48 start-page: 100 year: 2004 ident: ref_8 article-title: Oral delivery of meglumine antimoniate-beta-cyclodextrin complex for treatment of leishmaniasis publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.48.1.100-103.2004 contributor: fullname: Demicheli – volume: 347 start-page: 102 year: 2008 ident: ref_9 article-title: Enhanced oral delivery of antimony from meglumine antimoniate/β-cyclodextrin nanoassemblies publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2007.06.029 contributor: fullname: Martins – volume: 31 start-page: 109 year: 2010 ident: ref_10 article-title: Prolonged absorption of antimony(V) by the oral route from non-i nclusion meglumine antimoniate-beta-cyclodextrin conjugates publication-title: Biopharm. Drug Dispos. doi: 10.1002/bdd.695 contributor: fullname: Ribeiro – volume: 57 start-page: 4229 year: 2013 ident: ref_5 article-title: Amphiphilic antimony(V) complexes for oral treatment of visceral leishmaniasis publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.00639-13 contributor: fullname: Fernandes – volume: 1570 start-page: 192 year: 2002 ident: ref_12 article-title: Antimony(V) complex formation with adenine nucleosides in aqueous solution publication-title: Biochim. Biophys. Acta doi: 10.1016/S0304-4165(02)00198-8 contributor: fullname: Demicheli – volume: 325 start-page: 39 year: 2006 ident: ref_6 article-title: Mode of action of β-cyclodextrin as an absorption enhancer of the water-soluble drug meglumine antimoniate publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2006.06.014 contributor: fullname: Martins – volume: 347 start-page: 1739 year: 2002 ident: ref_3 article-title: Oral miltefosine for Indian visceral leishmaniasis publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa021556 contributor: fullname: Sundar – volume: 102 start-page: 656 year: 2008 ident: ref_7 article-title: New insights into the chemical structure and composition of the pentavalent antimonial drugs meglumine antimonate and sodium stibogluconate publication-title: J. Inorg. Biochem. doi: 10.1016/j.jinorgbio.2007.10.010 contributor: fullname: Frezard – volume: 359 start-page: 159 year: 2006 ident: ref_13 article-title: Synthesis and characterization of Sb(V)–adenosine and Sb(V)–guanosine complexes in aqueous solution publication-title: Inorg. Chim. Acta doi: 10.1016/j.ica.2005.09.003 contributor: fullname: Demicheli – volume: 7 start-page: e35671 year: 2012 ident: ref_1 article-title: Leishmaniasis worldwide and global estimates of its incidence publication-title: PLoS One doi: 10.1371/journal.pone.0035671 contributor: fullname: Alvar – volume: 7 start-page: 1343 year: 2010 ident: ref_11 article-title: New delivery strategies for the old pentavalent antimonial drugs publication-title: Expert Opin. Drug Deliv. doi: 10.1517/17425247.2010.529897 contributor: fullname: Demicheli |
SSID | ssj0021415 |
Score | 2.1893835 |
Snippet | Previous studies have shown that the association of the drug meglumine antimoniate (MA) with β-cyclodextrin can improve its bioavailability by the oral route.... |
SourceID | doaj pubmedcentral crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 5478 |
SubjectTerms | Administration, Oral Animals Antimony - administration & dosage Antimony - chemistry Biological Availability Carbohydrates - administration & dosage Carbohydrates - chemistry Circular Dichroism cyclodextrin Cyclodextrins Humans leishmaniasis maltose Meglumine - administration & dosage Meglumine - chemistry Meglumine Antimoniate Mice oral Organometallic Compounds - administration & dosage Organometallic Compounds - chemistry pentavalent antimonial drugs ribose |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NT4MwFG90F70Yv8Wv9OBBTcigQIHjPrPL1GRqvJGWlkkywQxYtv_eV2DLiAcv3ho-SvN-Le89-vj9ELqDtcydyLJ1n4Rctx0hdM4jVxfCt4UwuE-J-t95NHGfPrz-QNHkbKS-VE1YRQ9cGa5tEso8izPCTWEbTHhSGkbEPVM6oXRrGkmDrpOpOtUywS9Ve5gWJPXtr0pqVmbg_hzFYNXwQiVZ_5YHalZHbrmb4SE6qONE3KnGd4R2ZHKM9nprebYTtBjHSylwJ8nB2snq_v0Bq7U9k0uZYfV1Ffdr7ZMcT4op5K84T_E4FUqvS2KI-_AzPBd345QtWDyr-LpXOI3wi6onhxmobq37h1mK-_Nimp2it-HgtTfSaxEFPbSpk-sC8t9I0e5ZQtIQwi0GDfBXjpKOBGty5rOQQtZBABvGPQ6rXEKYEVqWpD68D85QK0kTeYEws6KIMBr5BgMbUsZMtekqXQ5RhAttDT2ujRp8V1wZAeQYCoHgFwIa6iqzby5UNNflAQA_qMEP_gJfQ-cVVptuCHRNqedqyG2g2HhO80wSf5a02pSoLV_n8j8GdoX2IbIqS3yId41a-byQN2g3E8VtOVF_AJzf8vM priority: 102 providerName: Directory of Open Access Journals |
Title | Mixed antimony(V) complexes with different sugars to modulate the oral bioavailability of pentavalent antimonial drugs |
URI | https://www.ncbi.nlm.nih.gov/pubmed/24786687 https://pubmed.ncbi.nlm.nih.gov/PMC6270655 https://doaj.org/article/126a83ba2b1d40ad8ee00fb81e5ce702 |
Volume | 19 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb5tAEB7VvjSXKE3zcNNae-ghiUQMCyxwTOxEubix5DbKDe2yi4tkQ2TjKP73neFh2cqtJ1bAPrQzy8zHzn4D8BPXsvJT17MinijL87W2lEoDS-vI09pWkeB03vlxGvx6CUf3RJPjt2dhqqD9RGU3-Xxxk2d_q9jK10UyaOPEBpPxUHDanPMHHeigb9hC9AZlOWiS6u1LF_H8YFFnmTUrtHw-kVcR_S9ehKAouh1bVFH279ih_RjJHaPzcASHjbfIbutRfYFPJj-Gz8M2SdtXeBtn70az27zEOc83l89XjFb43LybFaN_rGzUZEAp2XQ9QxTLyoKNC01ZuwxD7489Yb_sLivkm8zmNWv3hhUpm1BUOeohVW3aR11lo-V6tjqBPw_3v4ePVpNKwUo84ZeWRhScEvmeq41I0OmSWECr5VMCSR0aJSOZCMQeHCUkVahwrRt0NhLXNSLCr8IpdPMiN-fApJumXIo0siVOp5DSoa1XEyj0JQIs9-C6ndT4tWbMiBFpkDDiD8LowR1N-_ZFIruubhTLWdyIPHa4kKGrJFeO9myJwzW2narQMX5iApv34KyW1baZVsA9CPakuNfP_hPUtYpcu9Gtb_9d8wIO0Kmqont4-B265XJtfkBnpdf9CvD3K3X9ByCJ884 |
link.rule.ids | 230,315,729,782,786,866,887,2106,27933,27934,53800,53802 |
linkProvider | National Library of Medicine |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT-MwEB4t7IG9LLuwj8Ky-MABVgpNnMRJjtCCiqCAxEPcIjt2upHaBLUpgn_PTB6oFTdOseLYsfKNPTPx-BuAPZzLyk9dz4p4oizP19pSKg0srSNPa1tFgtN558FNcPkQ9k-IJsdvz8JUQfuJyg7z8eQwz_5XsZWPk6Tbxol1r4c9wWlzzu-uwGecr7bdOumNn-WgUqo3MF306LuTOs-smaHu84m-igiA8SIExdEtaKOKtH9BEy1HSS6ondP1Dw74G3xt7Ex2VFd_h08m34C1XpvebROehtmz0ewoLxGt_GX__oDR2jA2z2bG6O8s6ze5U0p2Mx-h_8vKgg0LTfm-DEO7kV3heNlxVsgnmY1rvu8XVqTsmuLRUYKpadM_SjnrT-ej2Q-4Oz257Q2sJgmDlXjCLy2N_nNKtH2uNiJBc01iAfWdT6kndWiUjGQi0GvhiK1UocJVwqCZkriuERGuJz9hNS9y8xuYdNOUS5FGtkQYhJQObdqaQKEVEmC5A_9aMOLHmmsjRh-FQIzfgdiBY4Lr7UGiya5uFNNR3Hz72OFChq6SXDnasyUO19h2qkLH-IkJbN6BXzXGb920gtGBYAn9pfcs1yDoFS13A_LWh1vuwtrgdngRX5xdnm_DFzTNqhghHv6B1XI6NzuwMtPzv5WwvwIH6whv |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9NAEB7RIgGX8qbhuQcOgOTaXttr-9gmjYogJVIBcbN2vbvBUmJHiVO1_54ZP6JE3ODklb0v-ZvdmfGOvwF4j2tZRTYInZTnygkjrR2lbOxonYZaeyoVnP53vriKL38lo3Oiydmm-mqC9nNVnJTzxUlZ_G5iK5eL3O3jxNzpZCg4Hc5F7lJb9wDu4pr1eO-od76Wj4qpPcQM0Kt3F22uWbNG_RcRhRWRAONFCIql29FIDXH_jjbaj5TcUT3jh_8x6Udw1Nmb7LSt8hjumPIJ3B_2ad6ewvWkuDGanZY1olbefvj5kdEeMTc3Zs3oKy0bdTlUana1maEfzOqKTSpNeb8MQ_uRfcM5s7OikteymLe837essmxKcekoydS06x-lnY1Wm9n6GfwYn38fXjhdMgYnD0VUOxr9aEv0fYE2IkezTWIB9V5EKSh1YpRMZS7Qe-GIsVSJwt3CoLmSB4ERKe4rz-GwrEpzDEwG1nIpbOpJhEJI6dPhrYkVWiMxlgfwqQckW7acGxn6KgRk9heQAzgjyLYViS67uVGtZln3_jOfC5kESnLl69CTOF3jeVYlvolyE3t8AC9anLfd9MIxgHhPAvbG2X-CwDf03B3QL_-55Tu4Nx2Ns6-fL7-8ggdooTWhQjx5DYf1amPewMFab9428v4HRRwK7w |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mixed+Antimony%28V%29+Complexes+with+Different+Sugars+to+Modulate+the+Oral+Bioavailability+of+Pentavalent+Antimonial+Drugs&rft.jtitle=Molecules+%28Basel%2C+Switzerland%29&rft.au=Ferreira%2C+Weverson+A.&rft.au=Islam%2C+Arshad&rft.au=Andrade%2C+Aretha+Priscilla+S.&rft.au=Fernandes%2C+Flaviana+R.&rft.date=2014-04-28&rft.pub=MDPI&rft.eissn=1420-3049&rft.volume=19&rft.issue=5&rft.spage=5478&rft.epage=5489&rft_id=info:doi/10.3390%2Fmolecules19055478&rft_id=info%3Apmid%2F24786687&rft.externalDBID=PMC6270655 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1420-3049&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1420-3049&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1420-3049&client=summon |